nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Cyamemazine—CHRM2—type 1 diabetes mellitus	0.0177	0.109	CrCbGaD
Propericiazine—Mequitazine—CHRM2—type 1 diabetes mellitus	0.0154	0.0949	CrCbGaD
Propericiazine—Ethopropazine—CHRM2—type 1 diabetes mellitus	0.015	0.0926	CrCbGaD
Propericiazine—Triflupromazine—CHRM2—type 1 diabetes mellitus	0.0123	0.0759	CrCbGaD
Propericiazine—Mesoridazine—CHRM2—type 1 diabetes mellitus	0.0108	0.0666	CrCbGaD
Propericiazine—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.0105	0.0645	CrCbGaD
Propericiazine—Propiomazine—CHRM2—type 1 diabetes mellitus	0.0091	0.0561	CrCbGaD
Propericiazine—Thioridazine—CHRM2—type 1 diabetes mellitus	0.00815	0.0503	CrCbGaD
Propericiazine—Methotrimeprazine—CHRM2—type 1 diabetes mellitus	0.00778	0.048	CrCbGaD
Propericiazine—Promethazine—CHRM2—type 1 diabetes mellitus	0.00766	0.0473	CrCbGaD
Propericiazine—Trifluoperazine—CHRM2—type 1 diabetes mellitus	0.00756	0.0466	CrCbGaD
Propericiazine—Quetiapine—CHRM2—type 1 diabetes mellitus	0.00733	0.0452	CrCbGaD
Propericiazine—Promazine—CHRM2—type 1 diabetes mellitus	0.00674	0.0416	CrCbGaD
Propericiazine—Chlorpromazine—CHRM2—type 1 diabetes mellitus	0.00593	0.0366	CrCbGaD
Propericiazine—Acepromazine—ALB—type 1 diabetes mellitus	0.0039	0.024	CrCbGaD
Propericiazine—Thioproperazine—ALB—type 1 diabetes mellitus	0.00381	0.0235	CrCbGaD
Propericiazine—Thiothixene—ALB—type 1 diabetes mellitus	0.00375	0.0231	CrCbGaD
Propericiazine—Pipotiazine—ALB—type 1 diabetes mellitus	0.00375	0.0231	CrCbGaD
Propericiazine—Liver injury—Ramipril—type 1 diabetes mellitus	0.00319	0.0734	CcSEcCtD
Propericiazine—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.00305	0.0702	CcSEcCtD
Propericiazine—Clomipramine—ALB—type 1 diabetes mellitus	0.00296	0.0183	CrCbGaD
Propericiazine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.0024	0.0552	CcSEcCtD
Propericiazine—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00222	0.051	CcSEcCtD
Propericiazine—ADRA2A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00218	0.00274	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00218	0.00274	CbGpPWpGaD
Propericiazine—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00214	0.0492	CcSEcCtD
Propericiazine—ADRA2A—Hemostasis—SELL—type 1 diabetes mellitus	0.0021	0.00264	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00209	0.00263	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00207	0.00261	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00205	0.00258	CbGpPWpGaD
Propericiazine—Chlorpromazine—ALB—type 1 diabetes mellitus	0.00203	0.0125	CrCbGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.002	0.00252	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00199	0.00251	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00198	0.0025	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	0.00198	0.00249	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00198	0.00249	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00189	0.00238	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00186	0.00234	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00184	0.00232	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00183	0.00231	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00182	0.0023	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00182	0.0023	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00181	0.00228	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00172	0.00217	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00171	0.00216	CbGpPWpGaD
Propericiazine—Asthma—Ramipril—type 1 diabetes mellitus	0.00168	0.0387	CcSEcCtD
Propericiazine—DRD1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00167	0.00211	CbGpPWpGaD
Propericiazine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00167	0.0383	CcSEcCtD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	0.00167	0.0021	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00166	0.00208	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00166	0.00208	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00165	0.00208	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—ITPR3—type 1 diabetes mellitus	0.00165	0.00207	CbGpPWpGaD
Propericiazine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00164	0.0377	CcSEcCtD
Propericiazine—ADRA1B—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00163	0.00205	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00161	0.00202	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00156	0.00196	CbGpPWpGaD
Propericiazine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00155	0.0357	CcSEcCtD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00155	0.00195	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SH2B3—type 1 diabetes mellitus	0.00155	0.00195	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00154	0.00194	CbGpPWpGaD
Propericiazine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00154	0.0353	CcSEcCtD
Propericiazine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00153	0.0352	CcSEcCtD
Propericiazine—ADRA1B—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00152	0.00192	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00151	0.0019	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00151	0.0019	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.0015	0.00189	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00149	0.00188	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00149	0.00188	CbGpPWpGaD
Propericiazine—Jaundice—Ramipril—type 1 diabetes mellitus	0.00146	0.0337	CcSEcCtD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00145	0.00183	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00144	0.00181	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00144	0.00181	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.0014	0.00177	CbGpPWpGaD
Propericiazine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.0014	0.0322	CcSEcCtD
Propericiazine—DRD1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.0014	0.00176	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00137	0.00173	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00136	0.00171	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00136	0.00171	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00135	0.0017	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00131	0.00165	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00128	0.00161	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00127	0.0016	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	0.00127	0.0016	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00126	0.00159	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00126	0.00159	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00126	0.00158	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00126	0.00158	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00125	0.00157	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS1—type 1 diabetes mellitus	0.00124	0.00156	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00123	0.00155	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HBA2—type 1 diabetes mellitus	0.00123	0.00154	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—ALB—type 1 diabetes mellitus	0.0012	0.00152	CbGpPWpGaD
Propericiazine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.0012	0.0277	CcSEcCtD
Propericiazine—ADRA1B—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00118	0.00149	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00118	0.00148	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.00116	0.00146	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00116	0.00146	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—G6PC2—type 1 diabetes mellitus	0.00115	0.00145	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00115	0.00144	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00114	0.00144	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00114	0.00144	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00113	0.00142	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00113	0.00142	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VAV1—type 1 diabetes mellitus	0.00113	0.00142	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00112	0.00141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00112	0.00141	CbGpPWpGaD
Propericiazine—Tremor—Ramipril—type 1 diabetes mellitus	0.0011	0.0253	CcSEcCtD
Propericiazine—DRD1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00108	0.00136	CbGpPWpGaD
Propericiazine—Agitation—Ramipril—type 1 diabetes mellitus	0.00108	0.0248	CcSEcCtD
Propericiazine—Angioedema—Ramipril—type 1 diabetes mellitus	0.00107	0.0247	CcSEcCtD
Propericiazine—ADRA1B—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00107	0.00135	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00105	0.00133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00105	0.00132	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00105	0.00132	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00104	0.00131	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00103	0.0013	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00103	0.0013	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00102	0.00129	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IGF2—type 1 diabetes mellitus	0.00102	0.00128	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCC8—type 1 diabetes mellitus	0.001	0.00126	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000989	0.00125	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000985	0.00124	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000978	0.00123	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000978	0.00123	CbGpPWpGaD
Propericiazine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000977	0.0225	CcSEcCtD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	0.000976	0.00123	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000974	0.00123	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000973	0.00122	CbGpPWpGaD
Propericiazine—Confusional state—Ramipril—type 1 diabetes mellitus	0.000965	0.0222	CcSEcCtD
Propericiazine—Oedema—Ramipril—type 1 diabetes mellitus	0.000957	0.022	CcSEcCtD
Propericiazine—DRD1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000956	0.0012	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000954	0.0012	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000945	0.00119	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00094	0.00118	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000936	0.00118	CbGpPWpGaD
Propericiazine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000934	0.0215	CcSEcCtD
Propericiazine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000926	0.0213	CcSEcCtD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000925	0.00116	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000922	0.00116	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00092	0.00116	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000916	0.00115	CbGpPWpGaD
Propericiazine—Hypotension—Ramipril—type 1 diabetes mellitus	0.000895	0.0206	CcSEcCtD
Propericiazine—ADRA1B—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000888	0.00112	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000884	0.00111	CbGpPWpGaD
Propericiazine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000866	0.0199	CcSEcCtD
Propericiazine—ADRA1B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000862	0.00109	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00086	0.00108	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.000858	0.00108	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000854	0.00108	CbGpPWpGaD
Propericiazine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000854	0.0196	CcSEcCtD
Propericiazine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000851	0.0196	CcSEcCtD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00085	0.00107	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000838	0.00105	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000826	0.00104	CbGpPWpGaD
Propericiazine—Constipation—Ramipril—type 1 diabetes mellitus	0.000819	0.0188	CcSEcCtD
Propericiazine—DRD1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000814	0.00103	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00081	0.00102	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000806	0.00102	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000803	0.00101	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000801	0.00101	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000801	0.00101	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000791	0.000995	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000783	0.000986	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000781	0.000983	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000777	0.000978	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000776	0.000976	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000772	0.000972	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000772	0.000972	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000772	0.000972	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000761	0.000958	CbGpPWpGaD
Propericiazine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000757	0.0174	CcSEcCtD
Propericiazine—ADRA1B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000753	0.000948	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00074	0.000931	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS2—type 1 diabetes mellitus	0.000738	0.000929	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000733	0.000922	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000729	0.000917	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000712	0.000896	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000711	0.000895	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00071	0.000893	CbGpPWpGaD
Propericiazine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000705	0.0162	CcSEcCtD
Propericiazine—ADRA2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000691	0.00087	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000678	0.000853	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000676	0.000851	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000675	0.00085	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000669	0.000842	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ITPR3—type 1 diabetes mellitus	0.000667	0.00084	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000667	0.00084	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000665	0.000838	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000661	0.000832	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000661	0.000832	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000657	0.000827	CbGpPWpGaD
Propericiazine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000655	0.0151	CcSEcCtD
Propericiazine—ADRA2A—Hemostasis—IGF1—type 1 diabetes mellitus	0.000655	0.000824	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000646	0.000814	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000645	0.000811	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000636	0.000801	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000632	0.000796	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000632	0.000796	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HBA1—type 1 diabetes mellitus	0.000628	0.000791	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOC3—type 1 diabetes mellitus	0.000624	0.000786	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000622	0.000782	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—ALB—type 1 diabetes mellitus	0.000621	0.000781	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	0.000613	0.000772	CbGpPWpGaD
Propericiazine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000609	0.014	CcSEcCtD
Propericiazine—ADRA1B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000606	0.000762	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000604	0.000761	CbGpPWpGaD
Propericiazine—Rash—Ramipril—type 1 diabetes mellitus	0.000604	0.0139	CcSEcCtD
Propericiazine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000603	0.0139	CcSEcCtD
Propericiazine—ADRA1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000597	0.000751	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	0.000594	0.000747	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000582	0.000732	CbGpPWpGaD
Propericiazine—Nausea—Ramipril—type 1 diabetes mellitus	0.000569	0.0131	CcSEcCtD
Propericiazine—DRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000565	0.000711	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000563	0.000709	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000558	0.000702	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000555	0.000699	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000553	0.000696	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00055	0.000693	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000542	0.000683	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000525	0.000661	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000522	0.000657	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000522	0.000657	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000514	0.000646	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000512	0.000644	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	0.000503	0.000633	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.0005	0.000629	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000495	0.000623	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000493	0.00062	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000493	0.00062	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	0.000488	0.000615	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000476	0.0006	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000471	0.000592	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000467	0.000588	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000463	0.000582	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000461	0.000581	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000458	0.000577	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000456	0.000574	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000444	0.000559	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000437	0.00055	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000431	0.000542	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000427	0.000538	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000421	0.000529	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000419	0.000527	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	0.000413	0.00052	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000408	0.000514	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000403	0.000508	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000393	0.000495	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000385	0.000485	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000383	0.000482	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000382	0.000481	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000381	0.000479	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000364	0.000458	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000359	0.000452	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000358	0.00045	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000353	0.000444	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.00035	0.00044	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000347	0.000437	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000346	0.000435	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INS—type 1 diabetes mellitus	0.00034	0.000427	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000333	0.000419	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000328	0.000413	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000327	0.000411	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000318	0.0004	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000316	0.000398	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000303	0.000382	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.0003	0.000378	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000298	0.000375	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000295	0.000372	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000294	0.00037	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000291	0.000366	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000289	0.000364	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	0.000278	0.00035	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	0.000274	0.000345	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000269	0.000339	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000268	0.000337	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000253	0.000318	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000252	0.000318	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	0.000252	0.000317	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000251	0.000316	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000248	0.000313	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000244	0.000307	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000243	0.000306	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	0.000241	0.000303	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000229	0.000289	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000222	0.000279	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000221	0.000278	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000212	0.000267	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000207	0.000261	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000207	0.00026	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000206	0.000259	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000205	0.000258	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000201	0.000253	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000193	0.000243	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000174	0.000219	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000171	0.000215	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000171	0.000215	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.00017	0.000214	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000158	0.000199	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000148	0.000187	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000144	0.000181	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.00013	0.000164	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000122	0.000153	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.0001	0.000126	CbGpPWpGaD
